Search Results 1621-1630 of 14651 for anti-TNF drugs
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4). The A4 study is investigating the effect of anti-amyloid treatment ...
Emtricitabine and tenofovir alafenamide combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is the ...
Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...
... anti-fibrotic and anti-remodeling drug as co-therapy during LVAD support. Participation eligibility. Participant eligibility includes age, gender, type and ...
... therapy must be resolved to ≤ Grade 1 or clinical baseline. Participants who are receiving chronic nonsteroidal anti-inflammatory drugs (NSAIDs) as treatment ...
Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... anti-hypertensive medications in the study eye; Is a known steroid ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Combipatch. Canadian Brand Name. Estalis ...
Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-cancer therapy for 2 years 14. Pregnant or lactating. If ?-HCG is ...
... therapy. Exclusion Criteria: Any patient who had previously received oral anti-cancer (OAM) therapy. Patient age < 18 years. Pregnancy. Participating Mayo ...
Systemic anti-lymphoma therapy within 28 days or use of antibody agents within 8 weeks use of radioimmunotherapy within 3 months; Known seropositive for or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.